Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action

Clin Neuropharmacol. 1987 Aug;10(4):384-7. doi: 10.1097/00002826-198708000-00010.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bromocriptine / administration & dosage*
  • Bromocriptine / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Levodopa / administration & dosage*
  • Levodopa / therapeutic use
  • Parkinson Disease / drug therapy*
  • Receptors, Dopamine / drug effects

Substances

  • Receptors, Dopamine
  • Bromocriptine
  • Levodopa